Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Payables: 2010-2025

Historic Payables for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $2.8 million.

  • Cryo Cell International's Payables rose 2831.87% to $2.8 million in Q3 2025 from the same period last year, while for Aug 2025 it was $2.8 million, marking a year-over-year increase of 2831.87%. This contributed to the annual value of $2.1 million for FY2024, which is 3854.42% down from last year.
  • Latest data reveals that Cryo Cell International reported Payables of $2.8 million as of Q3 2025, which was up 2831.87% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Cryo Cell International's Payables registered a high of $9.6 million during Q3 2022, and its lowest value of $1.8 million during Q4 2022.
  • For the 5-year period, Cryo Cell International's Payables averaged around $3.3 million, with its median value being $2.9 million (2023).
  • Its Payables has fluctuated over the past 5 years, first surged by 16263.09% in 2022, then tumbled by 6935.31% in 2023.
  • Cryo Cell International's Payables (Quarter) stood at $3.4 million in 2021, then plummeted by 48.17% to $1.8 million in 2022, then surged by 90.24% to $3.3 million in 2023, then crashed by 38.54% to $2.1 million in 2024, then soared by 35.97% to $2.8 million in 2025.
  • Its Payables stands at $2.8 million for Q3 2025, versus $2.4 million for Q2 2025 and $2.9 million for Q1 2025.